Bicycle Therapeutics (BCYC) Cash from Operations (2018 - 2026)

Bicycle Therapeutics has reported Cash from Operations for 9 years, with the latest figure at 65925000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 23.67% year-over-year to 65925000.0; the trailing twelve-month figure through Mar 2026 stood at 229230000.0 (down 27.19% YoY), and the FY2025 full-year result was 249675000.0, down 51.57% from the prior year.
• Cash from Operations for Q1 2026 stood at 65925000.0, down from 19346000.0 in the prior quarter.
• The five-year high for Cash from Operations was 34096000.0 in Q2 2023, with the low at 86370000.0 in Q1 2025.
• Historically, Cash from Operations has averaged 36886058.82 across 5 years, with a median of 39832000.0 in 2024.
• Annual changes were most pronounced in 2023 — Cash from Operations surged 244.9% — and 2024, when it tumbled 3786.05%.
• Bicycle Therapeutics' Cash from Operations stood at 30309000.0 in 2022, then slumped by 56.02% to 47288000.0 in 2023, then surged by 80.13% to 9396000.0 in 2024, then slumped by 105.9% to 19346000.0 in 2025, then slumped by 240.77% to 65925000.0 in 2026.
• The last three Cash from Operations figures came in at 65925000.0 (Q1 2026), 19346000.0 (Q4 2025), and 71173000.0 (Q3 2025), per Business Quant data.